Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Swan Winifred L Create: Alert

All | News | Filings
Date FiledTypeDescription
02/25/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2018 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Paid exercise price by delivering 1,350 shares @ $24.37, valued at $32.9k
Granted 13,971 restricted stock units @ $0
Exercised 4,657 restricted stock units @ $0
02/22/2018 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,500 shares @ $24.48, valued at $85.7k
Exercised 3,000 options to buy @ $11.03, valued at $33.1k
01/19/2018 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,500 shares @ $24.88, valued at $87.1k
Exercised 3,000 options to buy @ $11.03, valued at $33.1k
12/21/2017 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,500 shares @ $25.35, valued at $88.7k
Exercised 3,000 options to buy @ $11.03, valued at $33.1k
11/15/2017 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,500 shares @ $25.73, valued at $90.1k
Exercised 3,000 options to buy @ $11.03, valued at $33.1k
10/23/2017 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,500 shares @ $27.5, valued at $96.3k
Exercised 3,000 options to buy @ $11.03, valued at $33.1k
09/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/15/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/20/2017 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,500 shares @ $27.28, valued at $95.5k
Exercised 3,000 options to buy @ $11.03, valued at $33.1k
03/22/2017 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 15,723 shares @ $27.66, valued at $434.9k
Exercised 15,223 options to buy @ $18.59, valued at $283k
03/13/2017 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Granted 39,884 options to buy @ $27.89, valued at $1.1M
03/06/2017 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Paid exercise price by delivering 2,622 shares @ $28.31, valued at $74.2k
Exercised 7,919 restricted stock units @ $0
02/15/2017 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 16,049 shares @ $28.01, valued at $449.5k
Exercised 15,549 options to buy @ $18.48, valued at $287.3k
01/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/16/2016 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,500 shares @ $25.91, valued at $90.7k
Exercised 3,000 options to buy @ $11.03, valued at $33.1k
11/22/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/15/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/15/2016 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 620 shares @ $15.69, valued at $9.7k
Exercised 620 options to buy @ $9.96, valued at $6.2k
03/10/2016 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Granted 71,509 options to buy @ $15.58, valued at $1.1M
03/07/2016 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Paid exercise price by delivering 2,744 shares @ $15.48, valued at $42.5k
Exercised 7,919 restricted stock units @ $0
03/12/2013 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Paid exercise price by delivering 982 shares @ $11, valued at $10.8k
Exercised 3,056 restricted stock units @ $0
03/06/2013 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Granted 8,395 shares @ $0
Paid exercise price by delivering 4,202 shares @ $11.03, valued at $46.3k
Granted 11,025 restricted stock units @ $0
Exercised 3,675 restricted stock units @ $0
Granted 53,542 options to buy @ $11.03, valued at $590.6k
01/03/2013 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Paid exercise price by delivering 3,798 shares @ $11.25, valued at $42.7k
Exercised 11,981 restricted stock units @ $0
09/18/2012 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,000 shares @ $12.9558, valued at $38.9k
08/16/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
07/13/2012 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 3,000 shares @ $15.8848, valued at $47.7k
07/03/2012 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 2,541 shares @ $16.5001, valued at $41.9k
Exercised 1,000 options to buy @ $5.47, valued at $5.5k
Exercised 1,541 options to buy @ $4.54, valued at $7k
06/13/2012 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 2,541 shares @ $15.4786, valued at $39.3k
Sold 3,000 shares @ $15.1203, valued at $45.4k
Exercised 1,000 options to buy @ $5.47, valued at $5.5k
Exercised 1,541 options to buy @ $4.54, valued at $7k
05/11/2012 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Sold 2,541 shares @ $16.0207, valued at $40.7k
Sold 3,000 shares @ $15.56, valued at $46.7k
Exercised 1,000 options to buy @ $5.47, valued at $5.5k
Exercised 1,541 options to buy @ $4.54, valued at $7k
05/01/2012 4 Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.
Txns: Granted 9,494 shares @ $8.55, valued at $81.2k
Sold 9,494 shares @ $17.1709, valued at $163k
Exercised 9,494 options to buy @ $8.55, valued at $81.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy